期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
儿童期肝移植后长期生存者的肾功能不全的发生率较高
1
作者 Campbell K.M. Yazigi N. +1 位作者 ryckman f.c. 郭战宏 《世界核心医学期刊文摘(儿科学分册)》 2006年第A10期33-34,共2页
Objective: To determine the prevalence and identify variables associated with renal dysfunction in long- term survivors of pediatric liver transplantation. Study design: Data from 117 patients who survived ≥ 3 years ... Objective: To determine the prevalence and identify variables associated with renal dysfunction in long- term survivors of pediatric liver transplantation. Study design: Data from 117 patients who survived ≥ 3 years after liver transplantation were analyzed. Demographic and clinical information was obtained from chart review and from a clinical care database. The dependent variable was renal function as determined by measured glomerular filtration rate (mGFR). Univariate and multivariate analyses were performed to identify independent variables associated with renal dysfunction (mGFR < 70 mL/min per 1.73 m2). Results: The average time since liver transplant was 7.6 ± 3.4 years (range, 3 to 14.6 years). When the last available mGFR for all patients was analyzed, renal dysfunction was present in 32% . In the univariate analysis, mGFR at 1 year after transplant, cyclosporine immunosuppression, and time since transplant were significant; the second two were strongly collinear. Using multiple logistic regression modeling excluding time since transplant, cyclosporine and mGFR at 1 year after transplant were strongly associated with renal dysfunction. Conclusions: Renal dysfunction is a common complication in children who survive liver transplantation. Our observations are of critical importance because children may live long enough to move from a stage of renal insufficiency characterized by asymptomatic decreased GFR to symptomatic end- stage renal disease. 展开更多
关键词 肾功能不全 肝移植 生存者 童期 病历回顾 环孢霉素 肾小球滤过率 晚期肾病 临床医疗 参数变量
下载PDF
处理变异的新方法:肝移植受者的血液钙调神经磷酸酶抑制剂水平的门诊治疗监测
2
作者 Bucuvalas J.C. ryckman f.c. +1 位作者 Arya G. 郭战宏 《世界核心医学期刊文摘(儿科学分册)》 2006年第2期20-21,共2页
Objective: To apply the principles of statistical process control (SPC) to manage calcineurin inhibitor (CNI) blood levels. We hypothesized that the use of SPC would increase the proportion of CNI blood levels in the ... Objective: To apply the principles of statistical process control (SPC) to manage calcineurin inhibitor (CNI) blood levels. We hypothesized that the use of SPC would increase the proportion of CNI blood levels in the target range. Study design: The study population consisted of 217 patients more than 3 months after liver transplantation. After demonstration of proof of concept using the rapid cycle improvement process, SPC was applied to the entire population. The change package included definition of target ranges for CNI, implementation of a web-based tool that displayed CNI blood levels on a control chart, and implementation of a protocol and a checklist for management of CNI blood levels. The principal outcome measure was the proportion of CNI blood levels in the target range. Results: In the pilot study, the proportion of CNI blood levels in the target range increased from 50% to 85% . When the protocol was spread to the entire population, the proportion of drug levels in the target range increased to 77% from 50% (P < .001),whereas the range of CNI levels decreased. The rate of allograft rejection did not change. Conclusions: Utilization of SPC increased the proportion of CNI blood levels in target range. These observations may be applicable to the care of other chronic health care problems. 展开更多
关键词 磷酸酶抑制剂 治疗监测 钙调神经 肝移植受者 血液 同种异体移植物 门诊 新方 变异
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部